Established in 2018, the CRTCE is among the first clinics in Canada to specialize in ketamine therapy. The Montreal, QC location offers three different ketamine treatments as an alternative to mainstream oral medications. Of the millions who suffer from depression and mental health difficulties, many labor under conditions considered treatment-resistant. In both laboratory and clinical settings, ketamine has demonstrated its effectiveness and safety in treating these difficult to manage conditions. CRTCE Montreal, with expert staff and cutting-edge treatment, offers an alternative for those whose experience with mainstream treatments has been disappointing
Dr. Roger McIntyre is President of CRTCE. Along with an impressive list of credentials, Dr. McIntyre brings to the practice the inquisitive nature of a researcher. Dr. McIntyre’s research focuses on “identifying innovative, rapid acting psychotropic treatments for mood disorders,” research that benefits both the academic and public sectors. CRTCE combines this research focus with a patient first mandate to provide exemplary care for each individual seeking treatment at the clinic. Those seeking relief from treatment resistant symptoms will find a compassionate and effective treatment at CRTCE Montreal.